tiprankstipranks
Ortho Clinical Diagnostics Holdings (OCDX)
NASDAQ:OCDX
US Market

Ortho Clinical Diagnostics Holdings (OCDX) Financial Statements

0 Followers

Ortho Clinical Diagnostics Holdings Financial Overview

Ortho Clinical Diagnostics Holdings's market cap is currently ―. The company's EPS TTM is $-0.003; its P/E ratio is -4,764.86; Ortho Clinical Diagnostics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 500.10M$ 521.00M$ 522.50M$ 492.50M$ 506.80M
Gross Profit$ 250.60M$ 262.90M$ 270.10M$ 244.40M$ 258.60M
EBIT$ 49.20M$ -700.00K$ 55.40M$ 26.40M$ 5.90M
EBITDA$ 128.60M$ 80.80M$ 136.20M$ 109.50M$ 88.60M
Net Income Common Stockholders$ 14.80M$ -9.90M$ 14.70M$ -20.00M$ -39.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 68.60M$ 132.80M$ 153.80M$ 200.90M$ 255.90M
Total Assets$ 3.32B$ 3.36B$ 3.31B$ 3.30B$ 3.39B
Total Debt$ 2.25B$ 2.26B$ 2.28B$ 2.31B$ 2.39B
Net Debt$ 2.18B$ 2.13B$ 2.13B$ 2.11B$ 2.14B
Total Liabilities$ 2.87B$ 2.95B$ 2.91B$ 2.93B$ 3.02B
Stockholders Equity$ 375.60M$ 376.60M$ 396.90M$ 410.50M$ 443.30M
Cash Flow-
Free Cash Flow$ -31.00M$ 67.20M$ 57.80M$ 126.50M$ -23.30M
Operating Cash Flow$ -4.00M$ 98.40M$ 65.40M$ 132.70M$ -9.90M
Investing Cash Flow$ -27.20M$ -31.90M$ -7.40M$ 6.40M$ -10.70M
Financing Cash Flow$ 2.10M$ -12.80M$ -11.70M$ -91.30M$ 41.10M
Currency in USD

Ortho Clinical Diagnostics Holdings Earnings and Revenue History

Ortho Clinical Diagnostics Holdings Debt to Assets

Ortho Clinical Diagnostics Holdings Cash Flow

Ortho Clinical Diagnostics Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis